Peter Rizakos - Braxia Scientific G Counsel

All Insiders . USA . 
Stock . Braxia Scientific Corp . Stakeholders . Insider . Peter Rizakos
BRAXF Stock  USD 0  0  33.33%   

Insider

Peter Rizakos is G Counsel of Braxia Scientific Corp
Phone416-762-2138
Webhttps://braxiascientific.com

Braxia Scientific Management Efficiency

The company has return on total asset (ROA) of (0.2824) % which means that it has lost $0.2824 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0208) %, meaning that it generated substantial loss on money invested by shareholders. Braxia Scientific's management efficiency ratios could be used to measure how well Braxia Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Braxia Scientific Corp has accumulated 52.55 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Braxia Scientific Corp has a current ratio of 3.41, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Braxia Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Braxia Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Braxia Scientific Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Braxia to invest in growth at high rates of return. When we think about Braxia Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Aaqil AnwarATAI Life Sciences
N/A
Andrew SleeProtagenic Therapeutics
74
MEng CFAAntibe Therapeutics
N/A
Jean EpinatCellectis SA
N/A
Mythili MDMarker Therapeutics
46
David MackPmv Pharmaceuticals
62
Leila MDPmv Pharmaceuticals
61
Theis MDGH Research PLC
48
David LovejoyProtagenic Therapeutics
N/A
Greg CaversCybin Inc
53
Pr BayleyOxford Nanopore Technologies
N/A
Bart AndersonExicure
N/A
Dr MBACellectis SA
46
Tim CowperOxford Nanopore Technologies
N/A
Jordan HermanOxford Nanopore Technologies
N/A
Rutledge EllisBehnkeArch Therapeutics
N/A
Rhodri DaviesOxford Nanopore Technologies
N/A
MD MBAMind Medicine
N/A
Elias PapadimasExicure
48
MBA MBAAntibe Therapeutics
N/A
Christian AngermayerATAI Life Sciences
46
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. Braxia Scientific Corp. is headquartered in Toronto, Ontario. Braxia Scientific operates under Biotechnology classification in the United States and is traded on OTC Exchange. Braxia Scientific Corp [BRAXF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Equity-1.02
Return On Asset-0.28

Braxia Scientific Corp Leadership Team

Elected by the shareholders, the Braxia Scientific's board of directors comprises two types of representatives: Braxia Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Braxia. The board's role is to monitor Braxia Scientific's management team and ensure that shareholders' interests are well served. Braxia Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Braxia Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joshua Rosenblat, Chief Officer
Roger McIntyre, Chairman CEO
Stephen Brooks, Chief Officer
Peter Rizakos, G Counsel
Jason Wolkove, Chief Officer

Braxia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Braxia Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.02
Return On Asset-0.28
Operating Margin(4.42) %
Current Valuation4.7 M
Shares Outstanding240.72 M
Shares Owned By Insiders11.48 %
Shares Owned By Institutions0.34 %
Price To Book0.91 X
Price To Sales4.45 X
Revenue1.49 M

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Braxia Pink Sheet

Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY